149267-74-3

Basic information

• Product Name: Carbamic acid, [(1S)-2-(4-fluorophenyl)-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester
• CAS NO: 149267-74-3
• Molecular Formula: C14H20FNO3
• Molecular Weight: 269.316
• Mol File: 149267-74-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S)-2-(4-fluorophenyl)-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S)-2-(4-fluorophenyl)-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester(149267-74-3)
• EPA Substance Registry System: Carbamic acid, [(1S)-2-(4-fluorophenyl)-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester(149267-74-3)

Safety Data

• Hazardous Substances Data: 149267-74-3(Hazardous Substances Data)

Upstream product

• 41153-30-4 Boc-Phe(p-F) 
• 543-27-1 isobutyl chloroformate 
• 135545-01-6 tert-butyl N-[(1S)-1-[(4-fluorophenyl)methyl]-2-[methoxy(methyl)amino]-2-oxo-ethyl]carbamate 

Downstream Products

• 135544-90-0 (S)-tert-butyl (1-(4-fluorophenyl)-3-oxopropan-2-yl)carbamate 
• 135544-94-4 (5S,3E)-5-t-butoxycarbonylamino-6-(4-fluorophenyl)hex-3-enoic acid 
• 135545-02-7 (5S,3Z)-5-t-butoxycarbonylamino-6-(4-fluorophenyl)-1-trimethylhex-3-en-1-yne 
• 135544-92-2 (5S,3E)-5-t-butoxycarbonylamino-6-(4-fluorophenyl)-1-trimethylsilylhex-3-en-1-yne 

Relevant articles and documents

Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline

Synthetic tubulysins 24 a–m, containing non-hydrolysable N-substituents on tubuvaline (Tuv), were obtained in high purity and good overall yields using a multistep synthesis. A key step was the formation of differently N-substituted Ile-Tuv fragments 10 b

BENZO[C][2,7]NAPHTHYRIDINE DERIVATIVES, AND THEIR USE AS KINASE INHIBITORS

The present invention relates to Benzo[c] [2,7] naph thy ri dine Derivatives of formula (I), compositions comprising an effective amount of a Benzo[c] [2,7]naphthyridine Derivative, methods for treating or preventing a proliferative disorder or an autoimmune disease, comprising administering to a subject in need thereof an effective amount of a Benzo[c] [2,7]naphthyridine Derivative, methods for modulating PDK-I activity, PKA activity, Akt activity, S6K activity, or PKC activity, comprising administering to a subject in need thereof an effective amount of a Benzo[c] [2,7] naphthyridine Derivative. The invention also relates to processes for preparing a Benzo[c] [2,7] naphthyridine Derivative.

SYNTHESIS AND BIOLOGICAL ACTIVITIES OF BRADYKININ ANALOGUES WITH Ψ(E,CH=CH) AND Ψ(CH2-NH) ISOSTERIC PEPTIDE BOND REPLACEMENTS

The synthesis of bradykinin analogues is described in which the Gly4-Phe5, Phe5-Ser6 or the Pro7-Phe8 peptide bond has been replaced by a trans carbon-carbon double bond or by a "reduced" peptide bond.Some of the analogues display high potency and prolonged activity in the rat blood pressure test, indicating increased metabolic stability.A clear selectivity is obtained towards the myotropic effect in the guinea pig ileum.